5.75 +0.02 (0.35%)
After hours: 4:45PM EST
|Bid||5.72 x 1400|
|Ask||5.74 x 800|
|Day's Range||5.49 - 5.92|
|52 Week Range||4.05 - 12.52|
|Beta (3Y Monthly)||2.30|
|PE Ratio (TTM)||26.53|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Altria investment in Canadian cannabis producer Cronos sparked a rally in the broad cannabis sector and the its ETF. Will the trend continue?
is no longer just dipping its toe in the Mexican pharmaceutical marijuana economy - it announced Monday it agreed to acquire Farmacias Magistrales SA just days after it announced an exclusive partnership with the company. Farmacias recently became Mexico's first and only federally licensed importer, with a mandate to import raw materials containing THC and sell medical marijuana products containing over 1% THC. Aurora Cannabis said that Mexico's population of 130 million will have federally legal access to a range of the company's non-flower medical cannabis product line.
Just days after Aurora Cannabis Inc. announced a supply deal with Mexico’s Farmacias Magistrales SA, the Canadian cannabis company said it has entered a letter of intent to buy all of the company’s outstanding shares in an all-stock deal.
Leading marijuana producer Aurora Cannabis Inc (NYSE: ACB) has announced plans to establish a foothold in Mexico through the acquisition of Farmacias Magistrales. Canada-based Aurora Cannabis will acquire Farmacias Magistrales SA through an all-stock deal. The acquisition follows an agreement between Aurora Cannabis and Farmacias that calls for Aurora to supply the Mexican company with medical cannabis.
Four marijuana stocks to watch this week include Premier Health Group (OTC:PHGRF) (CSE:PHGI), Aurora Cannabis (ACB), Tilray (TLRY), and KushCo Holdings (KSHB). To put it into perspective, Canopy Growth reported 84,400 registered patients at September 30, 2016.
HENDERSON, NV / ACCESSWIRE / December 10, 2018 / One way to invest in the growing cannabis market is through energy companies. Indoor growing systems, using fans and lights, sometimes operate 24 hours ...
The Mexican market will soon be receiving medical cannabis. A partnership between Aurora Cannabis Inc (NYSE:ACB) and Farmacias Magistrales S.A. will ensure the steady supply of the medical pot to Mexico. Farmacias Magistrales is both a pharmaceutical manufacturer and distributor; the only one with an import license from the federal Mexican authorities. According to Terry […] The post Aurora Cannabis Partners With Farmacias Magistrales To Supply Medical Cannabis Products In Mexico appeared first on Market Exclusive.
NEW YORK, NY / ACCESSWIRE / December 10, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Aurora Cannabis Inc. (ACB), one of the world's largest and leading cannabis companies with funded capacity in excess of 500,000 kg per annum and sales and operations in 19 countries across five continents. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution. On December 7th, the company announced that it had established an exclusive partnership with Farmacias Magistrales S.A. ("Farmacias"), an established Mexican pharmaceutical manufacturer and distributor with a broad reach to approximately 80,000 retail points and 500 pharmacies and hospitals across Mexico.
Just days after Aurora Cannabis Inc. announced a supply deal with Mexico's Farmacias Magistrales SA, the Canadian cannabis company said it has entered a letter of intent to buy the company in a stock deal. Farmacias is Mexico's first and for now only federally licensed importer of raw materials containing THC, the psychoactive ingredient in cannabis, and has facilities to store and distribute medical products with more than 1% THC, Aurora said in a statement. The deal will give the company access to a market with more than 130 million people. Farmacias has about 80,000 retail outlets for selling CBD products and 500 pharmacies and hospitals to sell THC products. Aurora will pay for the deal with stock based on a valuation of the proforma revenue distribution projections of Farmacias. Aurora shares rose 1.2% premarket, but are down 23.8% in 2018, while the S&P 500 has fallen 1.5%.
WKN: A1C4WM) announced today that, further to the Company's press release dated December 7, 2018 , the Company has entered into a Letter of Intent to acquire all of the issued and outstanding shares of Farmacias Magistrales S.A. ("Farmacias"), subject to customary due diligence provisions, the completion of definitive agreements, and regulatory and government approval. As previously announced, Farmacias recently became Mexico's first and only federally licensed importer to date of raw materials containing THC, gaining the necessary licenses, facilities, and permissions to import raw THC material, and manufacture, store, and distribute medical cannabis products containing over 1% THC.
WKN: A1C4WM) announced today that, further to the Company's press release dated December 7, 2018, the Company has entered into a Letter of Intent to acquire all of the issued and outstanding shares of Farmacias Magistrales S.A. ("Farmacias"), subject to customary due diligence provisions, the completion of definitive agreements, and regulatory and government approval. As previously announced, Farmacias recently became Mexico's first and only federally licensed importer to date of raw materials containing THC, gaining the necessary licenses, facilities, and permissions to import raw THC material, and manufacture, store, and distribute medical cannabis products containing over 1% THC.
NEW YORK, NY / ACCESSWIRE / December 10, 2018 / Cannabis shares Aurora Cannabis and Cronos Group were both winning in Friday’s trading session on separate positive developments. Cronos Group saw big gains as traders learned that Marlboro maker Altria is planning to take a big stake in the company while Aurora Cannabis moved higher on an exclusive supply deal announcement. Aurora Cannabis Inc. shares were up 8.90% on Friday with about 22.2 million shares traded.
Danny Moses is a well-known investor who navigated the 2007-2008 financial crisis as the head trader at Steve Eisman's FrontPoint Partners. The story of how FrontPoint made a killing by betting against collateralized debt obligations has been documented in Michael Lewis’ book “The Big Short,” which was later adapted into a film by Adam McKay. Moses in October was appointed as the third independent member of Merida Capital Partners' six-person investment committee.
Shares of Aurora Cannabis Inc. shot up 10.8% in afternoon trade Friday, after the Canada-based marijuana company said it was expanding into Mexico with the establishment of an exclusive supply deal with Farmacias Magistrales S.A. The company said Farmacias, a pharmaceutical manufacturer and distributor that reaches 80,000 retail points and 500 pharmacies and hospitals, recently received the first import license graded from the Mexico's Federal Commission for Protection Against Health Risks, which allows the company to import medical cannabis containing THC. "This new exclusive partnership further expands Aurora's early mover advantage in Latin America, allowing us to become a leading player in the development of the medical cannabis system in Mexico, a legal market of 130 million people," said Aurora Chief Executive Terry Booth. The stock has lost 5.2% over the past three months, while the ETFMG Alternative Harvest ETF has shed 15.7% and the Dow Jones Industrial Average has lost 5.5%.
Farmacias is Sole Recipient of Federal License to Import, Formulate, Store and Sell Medical Cannabis Containing THC TSX | NYSE: ACB EDMONTON , Dec. 7, 2018 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" ...
Aurora Cannabis to Enter Mexico Market via Exclusive Supply Arrangement with Farmacias Magistrales
HENDERSON, NV / ACCESSWIRE / December 7, 2018 / The headline refers to cannabis, energy efficiency, and the profits that may be had by investors playing the two sectors. About 1% of all electricity consumption ...
While stocks have taken a beating due to trade concerns with China and rising rates, there is green at the end of the tunnel! With the expected vote and passage of the 2018 Farm Bill on Monday, stocks that are in the CBD space are poised to benefit and should run counter to the current market downward trends. Stocks in the CBD and cannabis space have not been immune from the market’s downturn, but the expected passage of the bill should provide an opportunity to acquire high growth stocks in this bear market. The 2018 Farm Bill will nationally legalize the cultivation and farming of that plant.
Cannabis News GB Sciences (OTCQB: GBLX) has entered into a master research and development agreement with the Louisiana State University Agricultural Center for joint research and development projects arising out of the production of therapeutic cannabis in Louisiana. The LSU selected GB Sciences subsidiary GB Sciences Louisiana as its public-private partner to cultivate and produce […] The post Cannabis Stock News Daily Roundup December 7 appeared first on Market Exclusive.
HENDERSON, NV / ACCESSWIRE / December 7, 2018 / The cannabis industry is using a lot of wattage, here are some companies to consider. Today we are highlighting: CleanSpark, Inc. (CLSK), Aurora Cannabis, ...
Canadian marijuana producer Aurora Cannabis Inc (NYSE: ACB) has been selected to supply medical cannabis to Luxembourg. After it was selected by the Health Ministry, Aurora Cannabis received all required authorizations for import and export of cannabis and has released its first shipment of medical cannabis to Luxembourg's Division de la Pharmacie et des Medicaments.
It might not be the invention of the automobile or the electric light, but the Dec. 3 announcement by Aurora Cannabis (NYSE:ACB) that it has received the go-ahead from Health Canada to sell cannabis softgel capsules for both the Canadian medical and adult-use recreational markets, is excellent news for owners of ACB stock. “Following our successful receipt of our sales license for softgels, we are now ready to start providing yet another type of delivery technology for our patients and customers,” stated Shane Morris, Aurora’s SVP of product development and regulatory affairs. “Production will be scaling up in the coming weeks, which will enable us to introduce this product to all our domestic and international target markets.
Receives Import and Export licenses and Commences Shipment to Luxembourg Market TSX | NYSE: ACB EDMONTON , Dec. 6, 2018 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") ...
Specifically, Reuters reported on Monday that the company behind Marlboro cigarettes, Altria (NYSE:MO), is in early talks to acquire Canadian cannabis company Cronos (NASDAQ:CRON). The Financial Times ran an article detailing that buyout interest in the cannabis sector is heating up, and that big name tobacco and beverage companies like Altria and Coca-Cola (NYSE:KO) have held multiple early-stage investment talks with cannabis players such as Cronos, Tilray (NASDAQ:TLRY), and Aurora (NYSE:ACB). The broad implication here is that big-time tobacco and beverage companies see the long-term potential of cannabis companies, and want to get in early, even if it means paying a premium.